As of November 10, 2026, 39 pharmaceuticals companies in Boston have filed a new SEC Form D on record, reporting $1.49B sold. 2 filed in the last 90 days, against 2 in the 90 days before. The biggest raise on record here is FOG PHARMACEUTICALS, INC., at $178M (SEC Form D, November 5, 2026).
2 pharmaceuticals companies in Boston filed in the last 90 days, against 2 in the 90 days before. The biggest raise on record here is FOG PHARMACEUTICALS, INC. at $178M.
Companies raising per week
The last 90 days
| Based | People named | |||
|---|---|---|---|---|
| Crosslink Therapeutics Inc. | $5.50M | 2026-10-20 | Boston, MA | Ronald Seidel, III, Andrew King +4 |
| BridgeHealth Pharmaceuticals, Inc. first filing | $3.50M | 2026-11-05 | Woburn, MA | Neal Muni, Indu Muni +1 |
First-time filers, last 90 days
BridgeHealth Pharmaceuticals, Inc..
Everything on record
| Based | People named | |||
|---|---|---|---|---|
| FOG PHARMACEUTICALS, INC. first filing | $178M | 2022-12-02 | Cambridge, MA | Gregory Verdine, Jeffrey Leerink +6 |
| Karyopharm Therapeutics Inc. first filing | $165M | 2022-12-08 | Newton, MA | Richard Paulson, Michael Mason +12 |
| Triana Biomedicines, Inc. first filing | $120.06M | 2025-12-04 | Lexington, MA | Patrick Trojer, David Grayzel +6 |
| Tango Therapeutics, Inc. first filing | $80.02M | 2023-08-24 | Boston, MA | Barbara Weber, Alan Huang +9 |
| Apnimed, Inc. | $79.75M | 2022-12-23 | Cambridge, MA | Lawrence Miller, Barry Wohl +7 |
| LEAP THERAPEUTICS, INC. first filing | $77.22M | 2023-03-13 | Cambridge, MA | Christine Granfield, Douglas Onsi +12 |
| Ratio Therapeutics, Inc. | $70M | 2026-07-31 | Boston, MA | John Hoppin, John Babich +7 |
| QurAlis Corp first filing | $59.98M | 2023-03-13 | Cambridge, MA | Kasper Roet, Chris Thomajan +12 |
| Corner Therapeutics, Inc. first filing | $50.94M | 2024-04-23 | Watertown, MA | Jonathan Kagan, Andrew Bellinger +4 |
| Ratio Therapeutics, Inc. first filing | $50.67M | 2023-12-21 | Boston, MA | John Hoppin, John Babich +9 |
| Ikena Oncology, Inc. first filing | $42.57M | 2023-08-18 | Boston, MA | Mark Manfredi, Jeffrey Ecsedy +10 |
| Matchpoint Therapeutics Inc. first filing | $42M | 2022-10-17 | Cambridge, MA | Andre Turenne, Bruce Booth +2 |
| Comanche Biopharma Corp. | $37.50M | 2024-01-17 | Concord, MA | Thomas Johnson, Muzammil Mansuri +9 |
| Comanche Biopharma Corp. first filing | $36.10M | 2023-05-12 | Concord, MA | Thomas Johnson, Ketan Patel +9 |
| Nocion Therapeutics, Inc. first filing | $31.11M | 2024-03-13 | Watertown, MA | Richard Batycky, Pini Orbach +8 |
| Relay Therapeutics, Inc. first filing | $30M | 2024-01-10 | Cambridge, MA | Sanjiv Patel, Brian Adams +10 |
| Apnimed, Inc. | $25M | 2026-03-27 | Cambridge, MA | Lawrence Miller, Barry Wohl +9 |
| Apnimed, Inc. | $23M | 2025-09-24 | Cambridge, MA | Lawrence Miller, Barry Wohl +9 |
| Nocion Therapeutics, Inc. | $23M | 2026-03-13 | Watertown, MA | Richard Batycky, Pini Orbach +8 |
| QurAlis Corp | $19.95M | 2025-09-05 | Cambridge, MA | Kasper Roet, Amy Schulman +9 |
| AXIAL THERAPEUTICS, INC. | $19.38M | 2025-02-11 | Woburn, MA | A. Campbell, Sarkis Mazmanian +5 |
| Land Medicine Inc. first filing | $16.91M | 2025-01-07 | Charlestown, MA | Tony Ho, Rob Hopfner +4 |
| Corner Therapeutics, Inc. | $16.75M | 2025-10-20 | Watertown, MA | Nick Seaver, Steven Altschuler +6 |
| Apnimed, Inc. | $16.50M | 2025-04-24 | Cambridge, MA | Lawrence Miller, Barry Wohl +8 |
| Sensorium Therapeutics, Inc. first filing | $15.51M | 2022-10-04 | Boston, MA | Richard Simon, Jerrold Rosenbaum +3 |
| Tango Therapeutics, Inc. | $15M | 2025-10-28 | Boston, MA | Barbara Weber, Daniella Beckman +7 |
| Sensorium Therapeutics, Inc. | $14.50M | 2025-02-12 | Boston, MA | Alexandra Glucksmann, Richard Simon +5 |
| AXIAL THERAPEUTICS, INC. first filing | $11.05M | 2023-10-27 | Woburn, MA | A. Campbell, James Blair +8 |
| Biofrontera Inc. | $11M | 2025-07-11 | Woburn, MA | Hermann Luebbert, Eugene Leffler, III +4 |
| Cristcot LLC | $10.47M | 2025-06-06 | Concord, MA | Jennifer Davagian, Henry Kay +5 |
| Slate Medicines, Inc. first filing | $10M | 2026-03-11 | Boston, MA | Andrew Levin, Cindy Xiong +4 |
| Solid Biosciences Inc. first filing | $9.20M | 2022-12-09 | Charlestown, MA | Alexander (Bo) Cumbo, Stephen DiPalma +16 |
| Biofrontera Inc. | $8M | 2024-03-05 | Woburn, MA | Hermann Luebbert, Eugene Leffler, III +4 |
| Cristcot LLC first filing | $6.99M | 2024-05-01 | Concord, MA | Jennifer Davagian, Henry Kay +5 |
| Crosslink Therapeutics Inc. | $5.50M | 2026-10-20 | Boston, MA | Ronald Seidel, III, Andrew King +4 |
| Acta Pharmaceuticals, Inc. first filing | $5.05M | 2023-04-07 | Boston, MA | George Alex, Rudolph Tanzi |
| Cyclerion Therapeutics, Inc. first filing | $5M | 2023-05-25 | Cambridge, MA | Peter Hecht, Anjeza Gjino +5 |
| General Oncology, Inc. | $4.81M | 2026-04-23 | Newton, MA | Jeffrey Glazier, Arnold Glazier +3 |
| 65 Therapeutics, Inc. first filing | $4.50M | 2024-12-06 | Somerville, MA | Julius Knowles, Murthy Chavali |
| Aveta Biomics, Inc. first filing | $4.46M | 2025-03-19 | Bedford, MA | Parag Mehta, S. P. Kothari +3 |
| Crosslink Therapeutics Inc. first filing | $4.25M | 2025-05-15 | Boston, MA | Ronald Seidel, III, Andrew King +3 |
| Biofrontera Inc. | $4.20M | 2024-12-05 | Woburn, MA | Hermann Luebbert, Eugene Leffler, III +4 |
| Eumentis Therapeutics, Inc. first filing | $4M | 2023-03-17 | Newton, MA | mark Tepper, James Larrick +4 |
| Biofrontera Inc. first filing | $3.68M | 2022-11-04 | Woburn, MA | John Borer, Beth Hoffman +6 |
| BridgeHealth Pharmaceuticals, Inc. first filing | $3.50M | 2026-11-05 | Woburn, MA | Neal Muni, Indu Muni +1 |
| Lucy Therapeutics, Inc. first filing | $3.45M | 2023-12-26 | Waltham, MA | Amy Ripka, Rachel Sha +1 |
| Andros Medicines Inc. first filing | $3.05M | 2026-07-01 | Boston, MA | John Maraganore, Khalil Barrage +1 |
| Windgap Medical, Inc. first filing | $2.30M | 2023-11-20 | Watertown, MA | Richard Russell, John Conley +10 |
| Lumina Pharmaceuticals Inc. first filing | $2M | 2025-06-20 | Boston, MA | Alma Sorensen, Peter Caravan +1 |
| Lennham Pharmaceuticals, Inc. first filing | $1.20M | 2023-04-04 | Concord, MA | Bradford Sippy, Benjamin Enerson +1 |
| Decoy Therapeutics, Inc. first filing | $1.02M | 2025-04-28 | Cambridge, MA | Frederick Pierce, Peter Marschel +2 |
| Eumentis Therapeutics, Inc. | $765K | 2024-06-26 | Newton, MA | Randall Marshall, Maryann Bryla +4 |
| AMORPHEX THERAPEUTICS HOLDINGS INC. first filing | $265K | 2023-01-20 | Andover, MA | Robert Thompson |
| Enveric Biosciences, Inc. | — | 2025-10-03 | Cambridge, MA | Joseph Tucker, Kevin Coveney +5 |
| Eutropics Pharmaceuticals, Inc. first filing | — | 2024-01-11 | Cambridge, MA | Michael Cardone |
| Sea Pharmaceuticals, LLC | — | 2023-10-11 | Cambridge, MA | James Pearson, Walter Brown +6 |
| Apnimed, Inc. | — | 2023-11-08 | Cambridge, MA | Lawrence Miller, Barry Wohl +7 |
| Sea Pharmaceuticals, LLC | — | 2025-05-14 | Cambridge, MA | James Pearson, Walter Brown +5 |
Reach the founders of these 39 Pharmaceuticals in Boston companies, each named in its filing, and keep them in one pipeline.
Start free in MentionFoxTurn your raise into a launch page, press kit and share cards, built from your own work.
Get your launch kitOther sectors in Boston
AI and software Biotech Health care Computers and hardware Energy and climate Agriculture Manufacturing Retail and restaurants Business services Telecom
Pharmaceuticals in other metros
Pittsburgh Washington, DC Miami New York Northern New Jersey Denver and Boulder San Francisco Bay Area Orlando and Tampa San Diego Philadelphia Raleigh-Durham Los Angeles Houston Dallas-Fort Worth Chicago Atlanta
How this list is built
Every company here filed a Form D with the SEC from this sector and metro. A Form D is the notice a company files when it sells shares or other securities without a public offering, so it catches seed rounds, small rounds and rounds that were never announced, alongside the large ones that make the news. Only new offerings by operating companies count: amendments, pooled investment funds, real estate vehicles and special purpose vehicles are left out, so each row is a company raising money for itself.
The amount shown is the total the filing reports as sold so far. Some filings report nothing sold yet; those rows show a dash and add nothing to the totals. "First filing" marks a company whose first Form D on record this is. Each company links to our page for the filing, or to the SEC's own copy, and the list can be copied as CSV for a spreadsheet.
Cite this page
https://mentionfox.com/funding/pharma/boston